Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sienna-Sabra is a 50/50 joint venture between Sienna Senior Living and Sabra Health Care REIT formed to acquire and own a portfolio of Canadian senior housing communities. The venture was created in connection with the acquisition of 11 private-pay retirement residences in Ontario and Saskatchewan from Extendicare, with Sienna serving as operator of the communities. Its business is not biotech or pharmaceutical drug development; rather, it is a commercial healthcare-services and healthcare real estate vehicle focused on seniors housing. The portfolio is predominantly independent living, with additional assisted living and memory care capacity to support aging in place.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sienna-Sabra.